Naloxone Prescribing in Primary Care: Why, Who, and How
Opioid overdose deaths rates are climbing and primary care physicians are on the front lines. Naloxone has revolutionized overdose prevention among people who use heroin but is underutilized in people who use prescription opioids. In this webinar, we will examine the history of naloxone, evidence for prescribing it in primary care, tips for getting patient buy-in, and strategies for implementing prescription programs in resource-limited settings.
ASAM and/or CSAM Members: Free
You must register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart."
This enduring internet activity is jointly provided by the California Society of Addiction Medicine (CSAM) and the California Health Care Foundation. CSAM is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
PA’s, nurses, pharmacists, psychologists and therapists can earn CEU credit.
- Primary care physicians who are implimenting medication assisted treatment of opioid dependence.
- Other clinicians who see patients dependent on opioids.
- Explain the evidence for overdose prevention with naloxone
- Discuss the impact of naloxone prescribing on patient and prescriber behavior
- Implement practical strategies for making naloxone available to at-risk patients in primary care settings
Diana Coffa, MD
Associate Professor, UCSF, Residency Program Director, Family and Community Medicine
Dr. Coffa and the planners of this activity have no relevant financial relationships to disclose
- 1.00 AMA Category 1
- 1.00 Attendance